Tag: Teva pharmaceuticals

Teva Pharmaceutical Industries is the world's largest generic medicines producer, providing a vast range of products to millions of patients daily. Due to its ubiquity, many people encounter the 'TEVA' imprint on different medications, leading to the common question, "Is TEVA a pain pill?" The simple answer is no, TEVA is a pharmaceutical company, and not a pill itself.

In the United States, about 90% of all dispensed prescriptions are for generic drugs [1.7.1]. If you see 'TEVA' imprinted on your pill, it means your medication is one of them. But what does TEVA mean on a prescription and what does it say about your medicine?

Did you know that Teva Pharmaceutical Industries Ltd. is one of the world's largest manufacturers of generic drugs, producing a vast range of medications for various conditions? Therefore, understanding what is a TEVA pill used for requires looking beyond the manufacturer's name and using the specific identifying code imprinted on each tablet.

As of September 2025, the combined monophasic oral contraceptive Sprintec is not discontinued and remains widely available from its manufacturer, Teva Pharmaceuticals. The widespread confusion about its status stems from a 2024 recall and prior shortages related to its triphasic sibling, Tri-Lo-Sprintec.

In 2014, the FDA determined that the brand-name Diamox tablets and intravenous solution were not withdrawn for safety or effectiveness reasons, despite being listed as discontinued. This clarification is crucial for patients asking, 'Is Diamox being discontinued?' because the active ingredient remains widely available.

Since its FDA approval in 1996 for ADHD and narcolepsy, Adderall has become a widely prescribed medication, with a generic version, amphetamine-dextroamphetamine, now commonly available as a more affordable alternative. This cost-effective option offers the same active ingredients and therapeutic effects as the brand-name drug.

With over 25 million Americans affected by asthma, many were concerned to hear about changes to their medication [1.6.5]. The crucial question is, **why was QVAR taken off the market?** The answer is not a safety recall, but a strategic business decision by its manufacturer, Teva [1.3.1].

The market for glatiramer acetate injections, a key treatment for multiple sclerosis, was initially dominated by Teva's brand-name product, Copaxone. However, with patent expirations and challenges, several companies have entered the market, offering generic alternatives. Discover who makes glatiramer acetate injections and learn about the competitive landscape that has emerged.

According to the U.S. Food and Drug Administration (FDA), the generic name for Synribo is omacetaxine mepesuccinate. This medication was developed to treat certain forms of chronic myeloid leukemia (CML) in patients who had become resistant to or intolerant of other therapies. It is important to note that Synribo has been permanently discontinued and is no longer available in the U.S. market.

First approved by the FDA in 1993, gabapentin is a widely prescribed anticonvulsant. Teva gabapentin, a generic version of the drug, is commonly used to manage certain types of seizures and relieve nerve pain.